For members

Keep what you find

Save experiences, gather them into lists of your own, share them and join the conversation under each one. An account is free.

Join free

Knowledge · Article

Enosis Therapeutics wants to optimise psychedelic therapy with VR

By Enosis Therapeutics

Enosis Therapeutics and Psylo are leveraging technology in Australia to advance medicinal psychedelic therapy, with Enosis focusing on virtual reality tools for integration therapy and Psylo developing non-hallucinogenic synthetic compounds. Australia has become the first country to legalize psychedelic-assisted therapies for conditions like treatment-resistant depression and PTSD.

Published
2022Where it sits among everything in the Knowledge Bank, by year
Author
Enosis Therapeutics

Summary

About the article

How Psylo and Enosis Therapeutics are using tech to tackle medicinal psychedelics

Australia is quickly becoming a global test case for medicinal psychedelic therapy. Two local startups, Enosis Therapeutics and Psylo, are taking distinct approaches to it through tech. While Enosis is pioneering virtual reality (VR) tools to support integration therapy, Psylo is developing synthetic compounds inspired by psychedelics that offer non-hallucinogenic therapeutic potential.

In July 2023, Australia became the first country in the world to legalise psychedelic-assisted therapies for conditions like treatment-resistant depression and post-traumatic stress disorder (PTSD).

Conversation

Share your experience of it

What it was like, what helped, what you would tell someone before they try it.

Be kind and stay on the subject. Staff remove what is not.

Related

More like this

Editor
Not recorded yet
Last reviewed
Not reviewed yet

New here? Create a free account

Tickets

Tickets

Search Cyberdelic Nexus